Covered recipient · General Payments record
MEGHAN BRYANNA SILLS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$9,496.61
- Reported across 135 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $507.63 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $219.54 | 18 |
| Lilly USA, LLC | $166.14 | 4 |
| Novo Nordisk AS | $40.08 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $34.40 | 2 |
| Acella Pharmaceuticals, LLC | $19.18 | 1 |
| Abbott Laboratories | $14.61 | 1 |
| Currax Pharmaceuticals LLC | $13.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.61 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125364138 | CMS |
| ABBVIE INC. | $8.52 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103771454 | CMS |
| ABBVIE INC. | $4.06 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103771456 | CMS |
| ABBVIE INC. | $7.60 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103771458 | CMS |
| ABBVIE INC. | $24.56 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103771460 | CMS |
| ABBVIE INC. | $15.50 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103771462 | CMS |
| ABBVIE INC. | $19.02 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103771464 | CMS |
| ABBVIE INC. | $20.17 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103771466 | CMS |
| ABBVIE INC. | $3.13 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103771468 | CMS |
| ABBVIE INC. | $6.92 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103771470 | CMS |
| ABBVIE INC. | $0.59 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103771472 | CMS |
| ABBVIE INC. | $28.00 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103771474 | CMS |
| ABBVIE INC. | $16.71 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103771476 | CMS |
| ABBVIE INC. | $18.17 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103771478 | CMS |
| ABBVIE INC. | $1.09 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103771480 | CMS |
| ABBVIE INC. | $14.44 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103771482 | CMS |
| ABBVIE INC. | $21.16 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103771484 | CMS |
| ABBVIE INC. | $0.94 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103771486 | CMS |
| ABBVIE INC. | $8.96 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103771488 | CMS |
| Acella Pharmaceuticals, LLC | $19.18 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126636220 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.47 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118256542 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.93 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118256540 | CMS |
| Currax Pharmaceuticals LLC | $13.68 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089513342 | CMS |
| Lilly USA, LLC | $20.75 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135199567 | CMS |
| Lilly USA, LLC | $12.22 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135208106 | CMS |
| Lilly USA, LLC | $116.99 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135181430 | CMS |
| Lilly USA, LLC | $16.18 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135208110 | CMS |
| Novo Nordisk Inc | $18.66 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097465547 | CMS |
| Novo Nordisk Inc | $21.42 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097440339 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.